{"nct_id":"NCT06514534","title":"Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-02-18","start_date_type":"ACTUAL","primary_completion_date":"2028-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2028-12-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}